Mansoura University Starts Pilot Clinical Trial Including Ivermectin Targeting COVID-19

Mansoura University Starts Pilot Clinical Trial including Ivermectin Targeting COVID-19

Mansoura University, founded as a branch of Cairo University back in 1972, established a faculty of medicine in the middle of the Nile Delta region. According to the Times Higher Education (THE) 2020 edition, the university is ranked No. 1 in Egypt and within the top 500 worldwide. Named after dinosaur ruins under the actual campus, the university’s medicinal scholars deal with modern day threats such as SARS-CoV-2, the pathogen behind the COVID-19 pandemic.  Recently, investigators there were the latest research team to investigate ivermectin as a potential treatment against COVID-19.


The university’s professors posit that the basis for the pathogenesis of the virus and its proliferation are unclear, and hence, there is no definitive treatment or vaccine to defend humans. So, medications are essentially based on effectiveness on in vitro studies, virtual screenings and records of their effects on earlier strains of coronavirus, SARS and MERS. They suggest that the prompt introduction of possible SARS-CoV-2 treatments can be both essential and salvaging.

Study Methodology

In this study, the Mansoura University investigators and study team seek to compare the...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee